Posts Tagged ‘CSL’
Patient advocate: FTC opposition to Talecris takeover is "ridiculous"
Monday, June 1, 2009, 8:31 pmA treatment for an inherited protein deficiency that causes lung and liver disease features prominently in the Federal Trade Commission’s request to block the $3.1 billion takeover of Talecris Biotherapeutics, one of the Research Triangle’s largest drugmakers.
Complaint: Producers keep prices for blood-based drugs high
Thursday, May 28, 2009, 7:30 pmAntitrust regulators alleged in a complaint filed Thursday that the two largest producers of four life-saving medicines made from blood plasma have figured out ways to keep prices high.
Talecris sale to be blocked
Monday, May 25, 2009, 8:59 pmThe $3.1 billion offer for Talecris Biotherapeutics, one of the Triangle’s largest drugmaker, raised antitrust questions from the very beginning.
